3 results
Approved WMOCompleted
The purpose of this current study is to evaluate the efficacy and safety of the 3-day oral aprepitant regimen when administered concomitantly with ondansetron, with or without dexamethasone, in pediatric patients, from 6 months to 17 years of age,…
Approved WMOCompleted
To evaluate the safety and performance of the Mobius HD system in subjects with resistant hypertension.
Approved WMOCompleted
To investigate the influence of aprepitant on the exposure to etoposide in TC patients treated with (B)EP.